Analysis and
Health
As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – and one is hair loss
By Grace Wade
Like all medications, GLP-1 drugs such as semaglutide – the active ingredient in Ozempic and Wegovy – have side effects
Iuliia Burmistrova/Getty Images
The use of weight loss treatments like Ozempic and Wegovy has skyrocketed in the Western world. But as more people turn to these treatments, which mimic the appetite-suppressing hormone GLP-1, more potential side effects are emerging, including hair loss.
Evidence of this first appeared during clinical trials of Wegovy. Of the more than 2100 adult participants taking the drug, 3 per cent experienced hair loss, compared with only 1 per cent of the roughly 1200 participants taking a…
More from New Scientist
Explore the latest news, articles and features
